| Issue Date | Title | Involved Person(s) |
| 10-Jun-2019 | Approaching target selectivity by de novo drug design | Fischer, Thomas; Gazzola, Silvia; Riedl, Rainer |
| 18-Feb-2019 | Titelbild: Von der Natur inspiriertes Wirkstoffdesign : kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts (Angew. Chem. 12/2019) | Gall, Flavio M.; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer |
| 18-Feb-2019 | Cover picture : drug design inspired by nature : crystallographic detection of an auto‐tailored protease inhibitor template (Angew. Chem. Int. Ed. 12/2019) | Gall, Flavio; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer |
| 5-Feb-2019 | Design and structural evolution of matrix metalloproteinase inhibitors | Fischer, Thomas; Senn, Nicole; Riedl, Rainer |
| 7-Jan-2019 | Von der Natur inspiriertes Wirkstoffdesign : kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts | Gall, Flavio; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer |
| 7-Jan-2019 | Drug design inspired by nature : crystallographic detection of an auto‐tailored protease inhibitor template | Gall, Flavio; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer |
| 30-May-2018 | Eine strukturelle Evaluierung medizinalchemischer Strategien gegen Wirkstoffresistenzen | Agnello, Stefano; Brand, Michael; Chellat, Mathieu; Gazzola, Silvia; Riedl, Rainer |
| 30-May-2018 | A Structural view on medicinal chemistry strategies against drug resistance | Agnello, Stefano; Brand, Michael; Chellat, Mathieu; Gazzola, Silvia; Riedl, Rainer |
| 2017 | Emodin : a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents | Abu Eid, Sameer; Adams, Michael; Scherer, Thomas; Torres-Gómez, Héctor Manuel; Hackl, Martina Theresa; Kaplanian, Mairam; Riedl, Rainer; Luger, Anton; Fürnsinn, Clemens |
| 2017 | Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase | Chellat, Mathieu F.; Riedl, Rainer |
| 2017 | Targeted polypharmacology : discovery of a highly potent non-hydroxamate dual matrix metalloproteinase (MMP)-10/-13 inhibitor | Senn, Nicole; Ott, Michael; Lanz, Jan; Riedl, Rainer |
| 2017 | Pseudouridimycin : das erste Nukleosid-Analogon, das bakterielle RNA-Polymerase selektiv inhibiert | Chellat, Mathieu F.; Riedl, Rainer |
| Sep-2016 | Emodin, a compound with acclaimed antidiabetic potential, deteriorates glucose tolerance in obese mice | Abu Eid, S.; Adams, M.; Scherer, T.; Torres-Gómez, H.; Hackl, M.T.; Riedl, R.; Luger, A.; Fürnsinn, C. |
| 24-Oct-2015 | Emodin, eine mutmaßlich anti-diabetisch wirksame Verbindung, beeinträchtigt die Glukosetoleranz adipöser Mäuse | Abu Eud, Sameer; Adams, Michael; Scherer, Thomas; Torres-Gomez, Hector; Riedl, Rainer; Luger, Anton; Fürnsinn, Clemens |
| 25-Feb-2015 | Cover Picture: Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural‐product‐derived fragments (ChemMedChem 3/2015) | Lanz, Jan; Riedl, Rainer |
